scholarly journals Pulmonary tuberculosis masquerading as metastatic lung disease

2016 ◽  
Vol 25 (139) ◽  
pp. 97-98 ◽  
Author(s):  
Vikas Pilaniya ◽  
Kamal Gera ◽  
Shekhar Kunal ◽  
Ashok Shah
1993 ◽  
Vol 16 (4) ◽  
pp. 395
Author(s):  
Eun Young Lee ◽  
Young Sun Hong ◽  
Seon Hee Cheon ◽  
Young Sik Park ◽  
Seung Yeon Baek ◽  
...  

2011 ◽  
Vol 26 (2) ◽  
pp. 268 ◽  
Author(s):  
Sei Won Lee ◽  
Young Sam Kim ◽  
Dong-Soon Kim ◽  
Yeon-Mok Oh ◽  
Sang-Do Lee

2017 ◽  
Vol 123 (2) ◽  
pp. 182-188 ◽  
Author(s):  
S. Tanadini-Lang ◽  
J. Rieber ◽  
A.R. Filippi ◽  
M.M. Fode ◽  
J. Streblow ◽  
...  

2020 ◽  
Vol 46 (2) ◽  
pp. e20180198-e20180198
Author(s):  
Eliane Viana Mancuzo ◽  
Eduardo Martins Netto ◽  
Nara Sulmonett ◽  
Vanessa de Souza Viana ◽  
Júlio Croda ◽  
...  

2020 ◽  
Vol 26 (4) ◽  
pp. 3449-3451
Author(s):  
Irena I. Gencheva ◽  

Introduction: Serum adenosine deaminase (ADA) levels are used to diagnose tuberculosis and to monitor the condition of the patients during hospital treatment. Purpose: The aim of the present study is to establish the diagnostic value of serum ADA in patients with inflammatory lung disease, including pulmonary tuberculosis. Materials and methods: We measured ADA levels in 66 patients with lung disease, of whom 33 were men and 33 were women, all aged 18 to 86 years. Among the patients studied, 12 were diagnosed with tuberculosis, 34 with bacterial pneumonia and 20 with pleural effusion. Results: We found that the serum ADA levels in our patients were higher than 18 U / l, which are the recommended upper limit in healthy people, according to the test performed by our laboratory. ADA levels were also higher than 21 U / l, the value we defined as the mean in healthy individuals in our previous study. Conclusion: Based on our study, we can say that serum ADA levels in the patients we have studied with lung diseases, including pulmonary tuberculosis, have a high diagnostic value.


2018 ◽  
Vol 64 (3) ◽  
pp. 319-324
Author(s):  
Yevgeniy Levchenko ◽  
VAN TIN ◽  
ChZhAN VEN ◽  
P. Kalinin ◽  
Tatyana Dubinina ◽  
...  

In order to create conditions for increasing the effectiveness of treatment of patients with metastatic lung disease a new method for calculating the dose of antitumor drug for performing isolated chemo-perfusion of the lung with metasta-sectomy taking into account the anatomical features of patients and previous operations on the lung was developed. The study consisted of three stages. As a result of the first stage of the study the effectiveness of the software package was measured in the volume of lung patients based on the presence of a strong positive correlation between the volumes of left lungs (Rs = 0.91, p


Sign in / Sign up

Export Citation Format

Share Document